A serum AFP level < 1200 ng/mL after SIOPEL neoadjuvant chemotherapy and no tumor recurrence were demonstrated to be predictors of native liver survival (hazard ratio: 4.54 and 5.55; P = 0.04 and 0.02; respectively) on Cox’s proportional hazard analysis (Table 3). The gene discussed is AFP; the disease is neoplasm.